7749.T
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company maintains a strong liquidity position, with a current ratio of 5.4, indicating a robust ability to meet short-term obligations. The liquidity_fpt metric further supports this, showing a high level of cash and equivalents at 21,559,317,000 JPY, which is a significant portion of its total assets. The company's return on equity (ROE) is 6.67%, and its return on assets (ROA) is 5.74%, both of which are indicators of efficient use of equity and assets to generate profit.
The company's profitability is reflected in its operating income of 4,485,379,000 JPY and net income of 3,013,544,000 JPY. These figures suggest a healthy margin, which is in line with the industry's preferred metrics. The debt-to-equity ratio is 0.02, indicating a low level of leverage and a conservative capital structure.
The company's revenue is concentrated in the healthcare services and equipment industry, with no significant geographic diversification mentioned in the available data. The company's exposure to this industry is a key factor in its business model, and any changes in the industry could impact its performance.
The company's growth trajectory is positive, with a revenue of 22,553,238,000 JPY. The outlook for the current fiscal year is favorable, with no immediate filing-based liquidity or dilution flags detected. The company's capital expenditure of -3,849,637,000 JPY indicates a significant investment in long-term assets, which could support future growth.
The company's risk assessment indicates a low level of liquidity and dilution risk. The absence of immediate filing-based liquidity or dilution flags suggests that the company is not currently facing significant financial risks. The company's conservative capital structure, with a low debt-to-equity ratio, further supports this assessment.
Recent events, as reflected in the financial data, show a strong performance with a last actual EPS of 204.55 JPY and a last actual revenue of 22,553,240,000 JPY. These figures indicate that the company is meeting or exceeding analyst expectations, which is a positive sign for investors.
- The company has a strong liquidity position with a current ratio of 5.4.
- The company's profitability is reflected in its operating income and net income, with a ROE of 6.67% and a ROA of 5.74%.
- The company's capital structure is conservative, with a low debt-to-equity ratio of 0.02.
- The company's growth trajectory is positive, with a revenue of 22,553,238,000 JPY.
- The company's risk assessment indicates a low level of liquidity and dilution risk.
- **margin_outlook_rationale**: The company's margin outlook is positive, driven by its strong operating income and net income.
- **rd_outlook_rationale**: The company's R&D outlook is not explicitly mentioned in the available data.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 7749.T Market data — financials · 2026-05-27
- Medikit Co Ltd Market data — analyst estimates · 2026-05-27